Results 41 to 50 of about 62,173 (364)

Risk of myeloid neoplasms after solid organ transplantation [PDF]

Leukemia, 2014
Solid organ transplant recipients have elevated cancer risks, owing in part to pharmacologic immunosuppression. However, little is known about risks for hematologic malignancies of myeloid origin. We linked the US Scientific Registry of Transplant Recipients with 15 population-based cancer registries to ascertain cancer occurrence among 207 859 solid ...
Morton, L M, Gibson, T M, Clarke, C A, Lynch, C F, Anderson, L A, Pfeiffer, R, Landgren, O, Weisenburger, D D, Engels, E A   +8 more
openaire   +4 more sources

Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications

Haematologica, 2010
Background Blastic plasmacytoid dendritic cell neoplasm is a rare malignancy that typically follows a highly aggressive clinical course in adults, whereas experience in children with this disease is very limited.Design and Methods This retrospective ...
Armin G. Jegalian, Nataliya P. Buxbaum, Fabio Facchetti, Mark Raffeld, Stefania Pittaluga, Alan S. Wayne, Elaine S. Jaffe   +6 more
doaj   +1 more source

Malignant tumors arising de novo in immunosuppressed organ transplant recipients [PDF]

, 1972
De novo malignant tumors have been observed throughout the world in 75 chronic survivors of organ transplantation, including 16 of our own patients. The incidence of tumors was approximately 80 times greater than in the average population in a comparable
Penn, I, Starzl, TE
core   +1 more source

Interventions for treating oral mucositis for patients with cancer receiving treatment [PDF]

, 2010
Background Treatment of cancer is increasingly effective but is associated with short and long term side effects. Oral and gastrointestinal side effects, including oral candidiasis, remain a major source of illness despite the use of a variety of agents ...
Clarkson, Jan E., Furness, Susan, Khalid, Tasneem, McCabe, Martin, Meyer, Stefan, Worthington, Helen V.   +5 more
core   +5 more sources

Yield of Screening Colonoscopy in Renal Transplant Candidates

Canadian Journal of Gastroenterology and Hepatology, 2015
BACKGROUND: Cardiovascular disease is the most common cause of death among patients with end-stage renal disease undergoing maintenance dialysis. Renal transplantation offers a survival advantage to patients with end-stage renal disease; it is also ...
Turki AlAmeel, Bahaa Bseiso, Meteb M AlBugami, Sami AlMomen, Lee Stuart Roth   +4 more
doaj   +1 more source

Haematological malignancy: are we measuring what is important to patients? A systematic review of quality of life instruments [PDF]

, 2019
© 2018 The Authors. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for
Goswami, Pushpendra, Khatib, Yasmin, Salek, Sam   +2 more
core   +1 more source

MEDIMP: 3D Medical Images with clinical Prompts from limited tabular data for renal transplantation [PDF]

arXiv, 2023
Renal transplantation emerges as the most effective solution for end-stage renal disease. Occurring from complex causes, a substantial risk of transplant chronic dysfunction persists and may lead to graft loss. Medical imaging plays a substantial role in renal transplant monitoring in clinical practice. However, graft supervision is multi-disciplinary,
arxiv  

Blastic Plasmacytoid Dendritic Cell Neoplasm: A Rapidly Progressive and Fatal Disease without Aggressive Intervention

Clinical Medicine Insights: Case Reports, 2013
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive myeloid neoplasm derived from plasmacytoid monocytes. The most common presentation involves cutaneous manifestations, which are often accompanied by bone marrow involvement.
Lindsey Prochaska, Christopher Dakhil, Sharad Mathur   +2 more
doaj   +1 more source

FoxO1 signaling in B cell malignancies and its therapeutic targeting

FEBS Letters, EarlyView.
FoxO1 has context‐specific tumor suppressor or oncogenic character in myeloid and B cell malignancies. This includes tumor‐promoting properties such as stemness maintenance and DNA damage tolerance in acute leukemias, or regulation of cell proliferation and survival, or migration in mature B cell malignancies.
Krystof Hlavac, Petra Pavelkova, Laura Ondrisova, Marek Mraz   +3 more
wiley   +1 more source

Mathematical models for order of mutation problem in myeloproliferative neoplasm: non-additivity and non-commutativity [PDF]

arXiv, 2023
In some patients of myeloproliferative neoplasm, two genetic mutations can be found: JAK2 V617F and TET2. When one mutation is present or not, the other mutation has different effects on regulating gene expressions. Besides, when both mutations are present, the order of occurrence might make a difference.
arxiv